Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Journal of the International AIDS Society|May 25, 2017
Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjectsGemma Hancock, Sara Morón-López, Jakub Kopycinski, et al.
BMJ Case Reports|January 19, 2026
Concomitant low-grade B-cell lymphoma and cervical intraepithelial neoplasiaCindy Wong Siaw Lin, Abhisek Ghosh, Neha Bhardwaj, et al.
Vaccine|January 20, 2016
Control of HIV-1 replication in vitro by vaccine-induced human CD8(+) T cells through conserved subdominant Pol epitopesTina Ahmed, Nicola J Borthwick, Jill Gilmour, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 6, 2024
Prognostic characteristics, recurrence patterns, and survival outcomes of vulval squamous cell carcinoma - A twelve-year retrospective analysis of a tertiary centreAhmed Darwish, Lamiese Ismail, Sanjiv Manek, et al.
Plos Pathogens|February 28, 2015
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responsesGemma Hancock, Hongbing Yang, Elisabeth Yorke, et al.
International Journal of STD & AIDS|May 7, 2016
Detecting asymptomatic Trichomonas vaginalis in females using the BD ProbeTec™ Trichomonas vaginalis Qx nucleic acid amplification testEmily Lord, Tana Newnham, Lucy Dorrell, et al.
Scientific Reports|November 2, 2022
Immune mobilising T cell receptors redirect polyclonal CD8+ T cells in chronic HIV infection to form immunological synapsesZoë Wallace, Jakub Kopycinski, Hongbing Yang, et al.
International Journal of Molecular Sciences|January 25, 2025
Modelling Endometriosis Using In Vitro and In Vivo SystemsVerity Black, Cemsel Bafligil, Erin Greaves, et al.
Vaccine|January 30, 2007
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapyLucy Dorrell, Patricia Williams, Annie Suttill, et al.
Plos One|July 19, 2017
Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimensNathifa Moyo, Nicola J Borthwick, Edmund G Wee, et al.
Pageof 10